Dietary modifications often provide the first line of symptom management: Eat smaller, more frequent meals rather than large portions, which can overwhelm the already-slowed digestive system Reduce intake of gas-producing foods such as beans, lentils, cruciferous vegetables (broccoli, cauliflower, cabbage), onions, and carbonated drinks Limit high-fat foods , as these delay gastric emptying further and may compound the medication's effects Consider a low-FODMAP approach under dietitian supervision if symptoms are persistent, as fermentable carbohydrates can contribute to bloating Stay well-hydrated with still water throughout the day to support digestive function Avoid eating close to bedtime , allowing at least 3 hours between the last meal and lying down Lifestyle adjustments can also prove beneficial: Regular physical activity , particularly gentle walking after meals, can stimulate gastrointestinal motility and help move gas through the digestive tract Stress management techniques such as mindfulness or breathing exercises, as stress can exacerbate gastrointestinal symptoms Maintaining a symptom diary to identify specific food triggers or patterns Medication-related strategies should be discussed with your prescribing healthcare professional: Slower dose titration may reduce the intensity of gastrointestinal side effects Pausing escalation or stepping back to a previously tolerated dose if symptoms are troublesome Timing of administration considerations (note that while most GLP-1 RAs are not meal-timed, exenatide immediate-release [Byetta] is taken before meals) Review of concurrent medications that may contribute to bloating, such as certain antibiotics, opioids, or iron supplements Over-the-counter remedies such as simeticone (an anti-foaming agent) or peppermint oil capsules may provide symptomatic relief for some individuals, though evidence for their effectiveness varies
Panel of Australian and New Zealand clinical toxicologists
I n skeletal muscle, IGF1R activation sensitizes IRS1 to degradation, and a screen for the responsible E3 ligase identified Fbxo40 as mediating this rapid turnover of IRS1, since IRS1 loss can be rescued by knockdown of Fbxo40
Proteomic and metabolomic markers: Machine learning approaches have identified panels of proteomic markers and metabolomic profiles that predict GLP-1RA response with high accuracy
Cancer Medicine 12, 59085925
For more top October Prime Day picks, check out The Hollywood Reporter s breakdown of Prime Day vs
